Want to join the conversation?
$VZ expects full-year 2016 adjusted earnings to plateau at a level comparable to its strong full-year 2015 adjusted earnings. $VZ projects adjusted EBITDA margin consistent with full-year 2015, and capital spending of $17.2-17.7Bil. Effective tax rate for financial reporting purposes is predicted to be 35-36%.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)